|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| C12N 15/90 | (2006.01) | ||
| C12N 15/85 | (2006.01) | ||
| C07K 16/00 | (2006.01) |
| (11) | Number of the document | 3766343 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20180508.2 |
| Date of filing the European patent application | 2017-11-03 | |
| (97) | Date of publication of the European application | 2021-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
| (46) | Date of publication of the claims translation | 2022-06-10 |
| (30) | Number | Date | Country code |
| 201662417845 P | 2016-11-04 | US | |
| 201762567932 P | 2017-10-04 | US |
| (72) |
GUO, Chunguang , US
HARRIS, Faith , US
VORONINA, Vera , US
MCWHIRTER, John , US
LEVENKOVA, Natasha , US
MACDONALD, Lynn , US
TU, Naxin , US
MURPHY, Andrew J , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gyvūnai, išskyrus žmogų, turintys sukonstruotą imunoglobulino lambda lengvosios grandinės lokusą |
| NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 9 | 208.00 EUR |
| 2026-11-03 |